Volatile organic compounds for the detection of hepatocellular carcinoma—A scoping review
Authors:
- Sayed MetwalySMSayed Metwaly
- Alicja PsicaAPAlicja Psica
- Opeyemi SogaoluOSOpeyemi Sogaolu
- Irfan AhmedIAIrfan Ahmed
- Ashis MukhopadhyaAMAshis Mukhopadhya
- Mirela DelibegovićMDMirela Delibegović
- Mohamed BekheitMBMohamed Bekheit
Open Access
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic reviewCancer Biomarkers, 2017
- Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?Liver International, 2016
- Volatile Biomarkers in Breath Associated With Liver Cirrhosis — Comparisons of Pre- and Post-liver Transplant Breath SamplesEBioMedicine, 2015
- Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic massHPB, 2014
- Noninvasive detection of lung cancer using exhaled breathCancer Medicine, 2013
- Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitroCancer Cell International, 2013
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- The Screening of Volatile Markers for Hepatocellular CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2010
- Incidence and Predictors of Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2007